Clinical Trial Update: Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase I trial evaluating adagrasib in combination with cetuximab and irinotecan for colorectal and colon cancer is active/not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer

Drugs mentioned

• Adagrasib (adagrasib)
• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colon Cancer, Colorectal Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING